HOME Top Market Reports eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2020

eClinical Solutions Market by Product (CDMS, EDC, CTMS, eCOA, Analytics, RTMS, eTMF, Safety), Delivery Mode (Web Hosted, On-premise, Cloud-based), Clinical Trial Phases, End User (Pharma/Biopharma Companies, CROs, Hospitals) - Global Forecast to 2020

By: marketsandmarkets.com
Publishing Date: February 2016
Report Code: HIT 2208

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


This report studies the eClinical solutions market over the forecast period of 2015 to 2020. The market is expected to reach USD 5.98 Billion by 2020, at CAGR of 12.1% from 2015 to 2020. Growing adoption of software solutions during clinical trials, increasing research and development expenditure by pharmaceutical companies, government grants to support clinical trials, and rising number of potential customers for eClinical solutions are some key factors fueling the growth of the market. Furthermore, increasing clinical research in emerging Asian countries, shift of clinical trials and resources from AMCs to CROs, developments of cost effective modules, and global rise in the number of clinical trials are offering new growth opportunities for market players. However, factors including high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are hampering the market growth.

Emerging markets including China, Korea, Taiwan, and India have become attractive destinations for outsourcing of clinical trials due to presence of large patient population and low operating cost in conducting clinical trials in these countries. Less stringent regulatory guidelines compared to developed nations in these countries, shortage of trial volunteers in Europe and North America, and growing number of life science research companies and CROs are the key factors propelling the demand for eClinical solutions in emerging markets. In order to leverage the high growth opportunities in these emerging nations, leading market players are expanding their presence in these countries.

As of 2014, Oracle Corporation (U.S.) held the leadership position in the global eClinical solutions market. Over the past three years, the company has adopted partnerships, agreements, and collaborations; new product launches and product enhancements; and product deployments as key business strategies to ensure its dominance in this market. Medidata Solutions, Inc. (U.S.) PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.) are some of the other key players in this market.

Scope of the Report

This research report categorizes the eClinical solutions market into the following segments:

By Product

  • Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
  • Clinical Trial Management Systems (CTMS)
  • Clinical Analytics Platform
  • Randomization and Trial Supply Management (RTMS)
  • Clinical Data Integration Platform
  • Electronic Clinical Outcome Assessment (eCOA)
  • Safety Solutions
  • Electronic Trail Master Files (eTMF)
  • Others (Regulatory Information Management Solutions, Coding Systems, and Core Laboratory Integration Solutions)

By Delivery Mode

  • Web-hosted (On-demand)
  • Licensed Enterprise (On-premise)
  • Cloud-based (SaaS)

By Clinical Trial Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Contract Research Organizations
  • Consulting Service Companies
  • Medical Device Manufacturers
  • Hospitals
  • Academic Research Institutions

By Region

  • North America
    • U.S.
    • Canada
  • Europe
  • Asia-Pacific
  • Rest of the World

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Breakdown of Primaries
                    2.1.2.2 Key Data From Primary Sources
                    2.1.2.3 Key Industry Insights
    2.2 Market Size Estimation
                    2.2.1.1 Bottom-Up Approach
                    2.2.1.2 Top-Down Approach
    2.3 Market Breakdown and Data Triangulation
    2.4 Research Assumptions

3 Executive Summary (Page No. - 29)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 35)
    4.1 Market Overview
    4.2 eClinical Solutions Market Size, By Product, 2013-2020 (USD Million)
    4.3 Geographic Analysis: eClinical Solutions Market, By Delivery Mode, 2015
    4.4 Market Share, By Clinical Trial Phase, 2015 vs 2020
    4.5 eClinical Solutions Market, By End User and Region, 2015

5 Market Overview (Page No. - 39)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Growing Adoption of Software Solutions During Clinical Trials
                    5.3.1.2 Government Grants to Support Clinical Trials
                    5.3.1.3 Need for Improved Data Standardization
                    5.3.1.4 Increasing Research and Development Expenditure By Pharmaceutical Companies
                    5.3.1.5 Growing Customer Base
           5.3.2 Restraints
                    5.3.2.1 High Implementation Costs
                    5.3.2.2 Dearth of Skilled Research Professionals
                    5.3.2.3 Lack of Awareness
           5.3.3 Opportunities
                    5.3.3.1 Increasing Clinical Research Activities in Emerging Asian Countries
                    5.3.3.2 Increasing Outsourcing of Clinical Trials to CROS
                    5.3.3.3 Development of Cost-Effective Modules
                    5.3.3.4 Rising Number of Clinical Trials
           5.3.4 Challenges
                    5.3.4.1 Low Adoption
                    5.3.4.2 Software Reliability
                    5.3.4.3 Patient Privacy

6 eClinical Solutions Market, By Product (Page No. - 46)
    6.1 Introduction
    6.2 Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
    6.3 Clinical Trial Management Systems (CTMS)
    6.4 Clinical Analytics Platforms
    6.5 Randomization and Trial Supply Management (RTSM)
    6.6 Clinical Data Integration Platforms
    6.7 Electronic Clinical Outcome Assessment (ECOA)
    6.8 Safety Solutions
    6.9 Electronic Trial Master File (ETMF)
    6.1 Other eClinical Solutions

7 eClinical Solutions Market, By Delivery Mode (Page No. - 64)
    7.1 Introduction
    7.2 Web-Hosted (On-Demand)
    7.3 Licensed Enterprise (On-Premise)
    7.4 Cloud-Based (SAAS)

8 eClinical Solutions Market, By Clinical Trial Phase (Page No. - 70)
    8.1 Introduction
    8.2 Phase I
    8.3 Phase II
    8.4 Phase III
    8.5 Phase IV

9 eClinical Solutions Market, By End User (Page No. - 80)
    9.1 Introduction
    9.2 Pharmaceutical and Biopharmaceutical Companies
    9.3 Contract Research Organizations
    9.4 Consulting Service Companies
    9.5 Medical Device Manufacturers
    9.6 Hospitals
    9.7 Academic Research Institutes

10 eClinical Solutions Market, By Region (Page No. - 90)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
     10.4 Asia-Pacific
     10.5 Rest of the World

11 Competitive Landscape (Page No. - 112)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Agreements, Partnerships, and Collaborations
             11.3.2 New Product Launches and Product Enhancements
             11.3.3 Product Deployment
             11.3.4 Mergers and Acquisitions
             11.3.5 Expansion
             11.3.6 Other Developments

12 Company Profiles (Page No. - 121)
(Overview, Financials, Products & Services, Strategy, & Developments)*
     12.1 Introduction
     12.2 Oracle Corporation
     12.3 Medidata Solutions, Inc.
     12.4 Parexel International Corporation
     12.5 Bioclinica, Inc. (A Subsidiary of JLL Partners)
     12.6 Datatrak International, Inc.
     12.7 CRF Health
     12.8 ERT
     12.9 eClinical Solutions, Inc.
     12.10 Merge Healthcare Incorporated
     12.11 Omnicomm Systems, Inc.

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 154)
     13.1 Discussion Guide*
     13.2 Introducing RT: Real-Time Market Intelligence
     13.3 Available Customizations
     13.4 Related Reports


List of Tables (70 Tables)

Table 1 U.S.: List of Some Life Science Startups Launched Between 2011 & 2014
Table 2 Global eClinical Solutions Market Size, By Product, 2013–2020 (USD Million)
Table 3 Global Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) Market Size, By Region, 2013–2020 (USD Million)
Table 4 North America: Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) Market Size, By Country, 2013–2020 (USD Million)
Table 5 Global Clinical Trial Management Systems (CTMS) Market Size, By Region, 2013–2020 (USD Million)
Table 6 North America: Clinical Trial Management Systems (CTMS) Market Size, By Country, 2013–2020 (USD Million)
Table 7 Global Clinical Analytics Platforms Market Size, By Region, 2013–2020 (USD Million)
Table 8 North America: Clinical Analytics Platforms Market Size, By Country, 2013–2020 (USD Million)
Table 9 Global Randomization and Trial Supply Management (RTSM) Market Size, By Region, 2013–2020 (USD Million)
Table 10 North America: Randomization and Trial Supply Management (RTSM) Market Size, By Country, 2013–2020 (USD Million)
Table 11 Global Clinical Data Integration Platforms Market Size, By Region, 2013–2020 (USD Million)
Table 12 North America: Clinical Data Integration Platforms Market Size, By Country, 2013–2020 (USD Million)
Table 13 Global Electronic Clinical Outcome Assessment (ECOA) Market Size, By Region, 2013–2020 (USD Million)
Table 14 North America: Electronic Clinical Outcome Assessment (ECOA) Market Size, By Country, 2013–2020 (USD Million)
Table 15 Global Safety Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 16 North America: Safety Solutions Market Size, By Country, 2013–2020 (USD Million)
Table 17 Global Electronic Trial Master File Market Size, By Region, 2013–2020 (USD Million)
Table 18 North America: Electronic Trial Master File (ETMF) Market Size, By Country, 2013–2020 (USD Million)
Table 19 Global Other eClinical Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 20 North America: Other eClinical Solutions Market Size, By Country, 2013–2020 (USD Million)
Table 21 Global eClinical Solutions Market Size, By Mode of Delivery, 2013–2020 (USD Million)
Table 22 Web-Hosted (On-Demand) eClinical Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 23 Licensed Enterprise (On-Premise) eClinical Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 24 Cloud-Based (SAAS) eClinical Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 25 Global eClinical Solutions Market Size, By Clinical Trial Phase, 2013–2020 (USD Million)
Table 26 eClinical Solutions Market Size for Phase I Clinical Trials, By Region, 2013–2020 (USD Million)
Table 27 North America: eClinical Solutions Market Size for Phase I Clinical Trials, By Country, 2013–2020 (USD Million)
Table 28 eClinical Solutions Market Size for Phase II Clinical Trials, By Region, 2013–2020 (USD Million)
Table 29 North America: eClinical Solutions Market Size for Phase II Clinical Trials, By Country, 2013–2020 (USD Million)
Table 30 eClinical Solutions Market Size for Phase III Clinical Trials, By Region, 2013–2020 (USD Million)
Table 31 North America: eClinical Solutions Market Size for Phase III Clinical Trials, By Country, 2013–2020 (USD Million)
Table 32 eClinical Solutions Market Size for Phase IV Clinical Trials, By Region, 2013–2020 (USD Million)
Table 33 North America: eClinical Solutions Market Size for Phase IV Clinical Trials, By Country, 2013–2020 (USD Million)
Table 34 Global eClinical Solutions Market Size, By End User, 2013–2020 (USD Million)
Table 35 eClinical Solutions Market Size for Pharmaceutical and Biopharmaceutical Companies, By Region, 2013–2020 (USD Million)
Table 36 Examples of Strategic Alliances Between CROS and Pharma Companies
Table 37 eClinical Solutions Market Size for Contract Research Organizations (CROS), By Region, 2013–2020 (USD Million)
Table 38 eClinical Solutions Market Size for Consulting Service Companies, By Region, 2013–2020 (USD Million)
Table 39 eClinical Solutions Market Size for Medical Device Manufacturers, By Region, 2013–2020 (USD Million)
Table 40 eClinical Solutions Market Size for Hospitals, By Region, 2013–2020 (USD Million)
Table 41 eClinical Solutions Market Size for Academic Research Institutes, By Region, 2013–2020 (USD Million)
Table 42 eClinical Solutions Market Size, By Region, 2013–2020 (USD Million)
Table 43 North America: eClinical Solutions Market Size, By Country, 2013-2020 (USD Million)
Table 44 North America: Market Size, By Product, 2013–2020 (USD Million)
Table 45 North America: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 46 North America: Market Size, By Clinical Trial Phase, 2013–2020 (USD Million)
Table 47 North America: Market Size, By End User, 2013–2020 (USD Million)
Table 48 U.S.: eClinical Solutions Market Size, By Product, 2013-2020 (USD Million)
Table 49 U.S.: Market Size, By Clinical Trial Phase, 2013-2020 (USD Million)
Table 50 Canada: eClinical Solutions Market Size, By Product, 2013-2020 (USD Million)
Table 51 Canada: Market Size, By Clinical Trial Phase, 2013-2020 (USD Million)
Table 52 European Medicines Agency (EMA)-Approved Biosimilars
Table 53 Europe: eClinical Solutions Market Size, By Product, 2013–2020 (USD Million)
Table 54 Europe: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 55 Europe: Market Size, By Clinical Trial Phase, 2013–2020 (USD Million)
Table 56 Europe: Market Size, By End User, 2013–2020 (USD Million)
Table 57 Asia-Pacific: eClinical Solutions Market Size, By Product, 2013–2020 (USD Million)
Table 58 Asia-Pacific: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 59 Asia-Pacific: Market Size, By Clinical Trial Phase, 2013–2020 (USD Million)
Table 60 Asia-Pacific: Market Size, By End User, 2013–2020 (USD Million)
Table 61 RoW: eClinical Solutions Market Size, By Product, 2013–2020 (USD Million)
Table 62 RoW: Market Size, By Delivery Mode, 2013–2020 (USD Million)
Table 63 RoW: Market Size, By Clinical Trial Phase, 2013–2020 (USD Million)
Table 64 RoW: Market Size, By End User, 2013–2020 (USD Million)
Table 65 Top 5 Agreements, Partnerships, and Collaborations, 2013–2015
Table 66 Top 5 New Product Launches and Product Enhancements, 2013–2015
Table 67 Top 5 Product Deployments, 2013–2015
Table 68 Top 5 Mergers and Acquisitions, 2013–2015
Table 69 Expansions, 2013–2015
Table 70 Top 5 Other Developments, 2013–2015

List of Figures (49 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Supply-Side Primary Interviews: By Company Type, Designation, and Region
Figure 3 eClinical Solutions Market: End-User Analysis Approach
Figure 4 Market: Bottom-Up Approach
Figure 5 Market: Top-Down Approach
Figure 6 Data Triangulation
Figure 7 Global eClinical Solutions Market, By Product, 2015 (USD Million)
Figure 8 Global Market Size, By Product, 2015 vs 2020
Figure 9 Global Market, By Delivery Mode, 2015 vs 2020
Figure 10 Global Market, By Clinical Trial Phase, 2015 vs 2020 (USD Million)
Figure 11 Global Market, By End User, 2015 vs 2020 (USD Million)
Figure 12 Global Market, By Region, 2015 (USD Million)
Figure 13 Emerging Countries Offer High Growth Opportunities
Figure 14 EDC & CDMS Segment Will Continue to Dominate the Global Market in 2020
Figure 15 Web-Hosted Delivery Mode Segment Dominates the Global Market in All Regional Segments
Figure 16 Phase III Clinical Trials Segment Will Continue to Dominate the Global Market in 2020
Figure 17 Asia-Pacific Contract Research Organizations Market is Expected to Witness the Highest Growth Rate Between 2015 and 2020
Figure 18 Market Segmentation
Figure 19 eClinical Solutions Market: Drivers, Restraints, Opportunities, and Challenges
Figure 20 The EDC and CDMS Segment to Command the Largest Share of the Global Market in 2015
Figure 21 North America is Estimated to Be the Largest Segment of the EDC and CDMS Market in 2015
Figure 22 Asia-Pacific Projected to Be the Fastest-Growing Region in the Clinical Trial Management Systems (CTMS) Market During the Forecast Period
Figure 23 North America is Estimated to Be the Largest Segment of the Clinical Analytics Platforms Market in 2015
Figure 24 Asia-Pacific Projected to Be the Fastest-Growing Region in the Randomization and Trial Supply Management (RTSM) Market
Figure 25 Web-Hosted (On-Demand) Segment to Dominate the Global eClinical Solutions Market in All Regions in 2015
Figure 26 Phase III Trials is the Fastest-Growing Market Segment in the Forecast Period
Figure 27 North America to Dominate the Global eClinical Solutions Market for Phase I Clinical Trials in 2015
Figure 28 Asia-Pacific Projected to Be the Fastest-Growing Region in the eClinical Solutions Market for Phase II Trials
Figure 29 North America is Estimated to Be the Largest Segment of the Global eClinical Solutions Market for Phase III Trials in 2015
Figure 30 Asia-Pacific Offers High Growth Opportunities for the Players in the eClinical Solutions Market for Phase IV Trials
Figure 31 Global eClinical Solutions Market Share, By End User, 2015
Figure 32 R&D Expenditure of the Top 10 Pharmaceutical Companies, 2013 vs 2014 (USD Million)
Figure 33 North America is Estimated to Be the Largest Segment of the Global eClinical Solutions Market for Pharma and Biopharma Companies in 2015
Figure 34 Asia-Pacific Projected to Be the Fastest-Growing Region in the eClinical Solutions Market for Contract Research Organizations
Figure 35 Global eClinical Solutions Market: Market Size & Growth Forecast, By Region (2015–2020)
Figure 36 North America: eClinical Solutions Market Snapshot
Figure 37 Europe: eClinical Solutions Market Snapshot
Figure 38 Europe: Number of Biosimilar Approvals, 2006-2014
Figure 39 Europe: Pharmaceutical R&D Expenditure, By Country (2012)
Figure 40 Asia-Pacific: eClinical Solutions Market Snapshot
Figure 41 Global eClinical Solutions Market Share, By Key Player, 2014
Figure 42 Battle for Market Share: Partnerships, Agreements, and Collaborations, the Key Growth Strategy for Market Players
Figure 43 Geographic Revenue Mix of the Leading Market Players
Figure 44 Oracle Corporation: Company Snapshot
Figure 45 Medidata Solutions, Inc.: Company Snapshot
Figure 46 Parexel International Corporation: Company Snapshot
Figure 47 Datatrak International, Inc.: Company Snapshot
Figure 48 Merge Healthcare Incorporated: Company Snapshot
Figure 49 Omnicomm Systems, Inc.: Company Snapshot

On the basis of product, the global eClinical solutions market is segmented into nine categories, namely, electronic data capture (EDC) and clinical data management systems (CDMS), clinical trial management systems (CTMS), clinical analytics platform, randomization & trial supply management systems (RTMS), clinical data integration platforms, electronic clinical outcome assessment (eCOA), safety solutions, electronic trail master files (eTMF), and others (regulatory information management solutions, coding systems, and core laboratory integration solutions). The electronic clinical outcome assessment (eCOA) segment is expected to grow at the highest CAGR in the next five years, owing to the increasing demand for eDiaries in clinical studies to collect patient self-reports by major pharmaceutical companies and increasing adoption of mobile and digital technologies.

This report studies the eClinical solutions market over the forecast period of 2015 to 2020. The market is expected to reach USD 5.98 Billion by 2020, at CAGR of 12.1% from 2015 to 2020.

Based on the type of delivery mode, the eClinical solutions market is classified into three segments, namely, web-hosted (On-demand), licensed enterprise (On-premise), cloud-based (SaaS). On the basis of clinical trial phase, the market is segmented into phase I, phase II, phase III, and phase IV. The market has also been classified into six segments based on the end user, namely, pharmaceutical and biopharmaceutical companies, contract research organizations, consulting service companies, medical device manufacturers, hospitals, and academic research institutions.

The global eClinical solutions market is estimated to grow at a CAGR of 12.1% from 2015 to 2020. A number of factors such as growing adoption of software solutions during clinical trials, increasing research and development expenditure by pharmaceutical companies, growing government grants to support clinical trials, and rising customer base are propelling the growth of the global market. However, high implementation cost, dearth of skilled research professionals, and lack of awareness of clinical data sciences software in research community are some of the major factors restraining the growth of this market. In addition to this, challenges associated with this market such as low adoption rate in certain geographies and software reliability and patient privacy issues related with eClinical solutions are also limiting the demand for these solutions.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, the global eClinical solutions market is estimated to be dominated by North America. A number of factors such as increasing government grants to support clinical trials, continuous product development and new product launches by eClinical solution vendors, growth in the number of partnerships for new drug development, and high prevalence of lifestyle diseases with increasing aging population are driving the growth of the market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2015 to 2020. This is primarily due to the increasing outsourcing of clinical trials by big pharmaceutical and biopharmaceutical organizations to developing Asian countries, growth in government funding to support clinical research, presence of less stringent regulatory guidelines compared to developed nations to conduct clinical trials, presence of a large patient base, and faster patient recruitment for clinical trials in this region.

Partnerships, agreements, and collaborations is the key growth strategy adopted by major players to develop their positions in the global eClinical solutions market. Moreover, strategies such as new product launches and product enhancements; product deployments; mergers, and acquisitions; and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their geographic presence in the global market.

Oracle Corporation (U.S.), Medidata Solutions, Inc. (U.S.), PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), CRF Health (U.S.), DATATRAK International, Inc. (U.S.), ERT (U.S.), eClinical Solutions, Inc. (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S.) are some of the key players operating in the global eClinical solutions market.

Available Customizations Title

Client Consult Problem Statement :
  • MnM’s Client was wanting to understand the newly developed E-Clinical Suite by a Global Healthcare IT consulting firm.
  • The client needed to understand the product standing against top competitors such as Oracle and MediData to plan their marketing and product positioning.
  • The client also wanted to understand the gaps in the product directly from the end users of E-clinical solutions globally. Receive rating and comparison of the product from the end users for product enhancement.

Solution Provided:
  1. Methodology Adopted by MnM :MnM conducted multi-level, qualitative & quantitative stud....
  1. Methodology Adopted by MnM :MnM conducted multi-level, qualitative & quantitative study with a constructed sample of mid to senior level management executives as well as hands on industry professionals. Key parameters influencing the market are identified and their trends were studied to get the market numbers. At every level the estimates were verified with industry experts (both from demand and supply side) and finally by in-house domain experts. Both, top-down and bottom-up approaches were used to use to derive unbiased information. MnM analyzed current & forecast quantitative market information, and developed deep-dive qualitative insights into industry trends & dynamics across each of the target countries.
  2. Actual Solution Provided:
  • Estimation of historical, current, and forecasted market size for global hemophilia treatment market, based on type of hemophilia, drug class, and geography
  • Profiling of leading players and estimation of their market share in global hemophilia market
  • Analyzing various macro and micro factors impacting market growth
  • In depth country level analysis for identified priority market with information on growth factors, challenges, and competition activities
  • Estimation of patient base at country level as well as at regional level – disease prevalence, diagnosed and treated population
  • Strategic insights for different possible approaches to enter into the priority markets with new product

Value Delivered:

Client could identify the market potential and was able to identify priority markets for the launch of its new product. Additionally, the study helped client with different competitive strategies to enter into the market.

less...
Request Customization
 more...

Client Consult Problem Statement :

MnM’s client, a leading provider of surgical instrument tracking solutions, was interested in estimating market in terms of volume (installed base) as well as value. In addition to this, in-depth end-user analysis was client’s special focus area. The scope included study of market dynamics, in-depth market and technology assessment of tracking solutions, market forecast for 5 years, identification of market share of key players, regional level analysis of each product segment and competitive landscape.

Solution Provided:
  1. Methodology Adopted by MnM : MnM conducted multi-level, qualitative & quantitative stu....
  1. Methodology Adopted by MnM : MnM conducted multi-level, qualitative & quantitative study with a constructed sample of end users (including sterile processing managers, directors, purchase managers, IT professionals) as well as industry professionals. Key parameters influencing the market are identified and their trends were studied to get the market numbers. At every level the estimates were verified with industry experts (both from demand and supply side) and finally by MarketsandMarkets domain experts. Both, top-down and bottom-up approaches were used to use to derive at an unbiased data. MnM analyzed current & forecast quantitative market information, and developed deep-dive qualitative insights into industry trends & dynamics across each of the target segments
  2. Actual Solution Provided:
  • Market sizing and forecast for instrument tracking solutions by facility type, technology, component
  • Analysis of the market trends and dynamics across different states in the U.S. leading to the overall market size and growth in each state
  • Identified companies in the market including financial strengths and growth strategies
  • Detailed analysis of end-user need-gap, preferences, product features and insights into the selection and adoption of instrument tracking solution products
  • Strategic insights for market penetration and positioning

Value Delivered:

The study assisted the client in knowing the market potential and dynamics, studying its competitors and their strategies and most importantly, understanding key stakeholders and customer requirements better. It also offered the client an understanding about the satisfaction levels and concerns amongst hospitals with regards to their currently installed systems. This helped the client to develop better solutions and devise the best possible market penetration strategies.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Healthcare IT Markets on KnowledgeStore
Request Demo Now